Invesco Ltd. Nemaura Medical Inc. Transaction History

Invesco Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 17, 2021	SELL	$4.7 - $16.7 $71,266 - $253,222	-15,163 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.79 - $9.78 $765 - $1,975	202 Added 1.35%	15,163 $116,000
Q4 2020 Feb 16, 2021	BUY	$3.47 - $4.52 $51,914 - $67,623	14,961 New	14,961 $56,000

Ticker NMRD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,102,900
Market Cap $723K
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.